China Molecular Cytogenetics Market Size & Outlook
Related Markets
China molecular cytogenetics market highlights
- The China molecular cytogenetics market generated a revenue of USD 158.9 million in 2024 and is expected to reach USD 480.5 million by 2033.
- The China market is expected to grow at a CAGR of 13.3% from 2025 to 2033.
- In terms of segment, oncology was the largest revenue generating application in 2024.
- Personalized Medicine is the most lucrative application segment registering the fastest growth during the forecast period.
Molecular cytogenetics market data book summary
| Market revenue in 2024 | USD 158.9 million |
| Market revenue in 2033 | USD 480.5 million |
| Growth rate | 13.3% (CAGR from 2025 to 2033) |
| Largest segment | Oncology |
| Fastest growing segment | Personalized Medicine |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Genetic Disorders, Oncology, Personalized Medicine, Other |
| Key market players worldwide | Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Illumina Inc, Sysmex Corp, Roche Holding AG, BioView, MetaSystems, Agilent Technologies Inc, Revvity Inc |
Other key industry trends
- In terms of revenue, China accounted for 6.6% of the global molecular cytogenetics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan molecular cytogenetics market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 480.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Molecular Cytogenetics Market Scope
Molecular Cytogenetics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MetaSystems | View profile | 11-50 | Newton, Massachusetts, United States, North America | https://metasystems-international.com/us/ |
| BioView | View profile | 1-10 | Rehovot, HaMerkaz, Israel, Asia | http://www.bioview.co.il/HTMLs/Home.aspx |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Revvity Inc | View profile | 11500 | 940 Winter Street, Waltham, MA, United States, 02451 | https://www.revvity.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
China molecular cytogenetics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular cytogenetics market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 44.05% in 2024. Horizon Databook has segmented the China molecular cytogenetics market based on genetic disorders, oncology, personalized medicine, other covering the revenue growth of each sub-segment from 2021 to 2033.
With a population of 1.41 billion, the incidence of genetic diseases is high in the country. Current estimates show that there are more than 10 million people living with chromosomal diseases and more than one million people with monogenic disorders.
However, public healthcare in China has been rapidly improving since the past two decades. Unlike the previous structure, most of the healthcare has become public and is easily accessible. Government & private funding has led the market growth as funding of more than 40% was through private manufacturers, which has been monumental for research institutes to innovate and develop novel technology platforms.
Government initiatives like free testing for genetic diseases and cancer detection has helped improve healthcare access in remote parts of the country, which increased the need for rapid and novel platform for genetic testing; thereby boosting market growth.
Reasons to subscribe to China molecular cytogenetics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China molecular cytogenetics market databook
-
Our clientele includes a mix of molecular cytogenetics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China molecular cytogenetics market , including forecasts for subscribers. This country databook contains high-level insights into China molecular cytogenetics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
China molecular cytogenetics market size, by application, 2021-2033 (US$M)
China Molecular Cytogenetics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
